Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 9,361 | 19,530 | 5,331 | 5,352 | 11,397 |
| Gross Profit | 9,361 | 19,530 | 5,331 | 5,352 | 11,397 |
| Operating Expenses | 56,008 | 51,246 | 59,566 | 56,149 | 54,508 |
| Operating Income | -46,647 | -31,716 | -54,235 | -50,797 | -43,111 |
| Interest Expense | 824 | 821 | 820 | 814 | 821 |
| Other Income | 7,774 | 5,624 | 6,276 | 3,985 | 812 |
| Pre-tax Income | -39,697 | -26,913 | -48,779 | -47,626 | -43,120 |
| Income Tax | 115 | -350 | 320 | 2,272 | -517 |
| Net Income Continuous | -39,812 | -26,563 | -49,099 | -49,898 | -42,603 |
| Net Income | $-39,812 | $-26,563 | $-49,099 | $-49,898 | $-42,603 |
| EPS Basic Total Ops | -0.77 | -0.62 | -1.11 | -1.26 | -1.41 |
| EPS Basic Continuous Ops | -0.77 | -0.62 | -1.10 | -1.26 | -1.41 |
| EPS Diluted Total Ops | -0.77 | -0.62 | -1.11 | -1.26 | -1.41 |
| EPS Diluted Continuous Ops | -0.77 | -0.62 | -1.10 | -1.26 | -1.41 |
| EPS Diluted Before Non-Recurring Items | -0.77 | -0.62 | -1.16 | N/A | N/A |
| EBITDA(a) | $-45,007 | $-30,058 | $-52,581 | $-49,107 | $-41,466 |